<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8100316</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1138</journal-id>
<journal-id journal-id-type="nlm-ta">Biomaterials</journal-id>
<journal-id journal-id-type="iso-abbrev">Biomaterials</journal-id>
<journal-title-group>
<journal-title>Biomaterials</journal-title>
</journal-title-group>
<issn pub-type="ppub">0142-9612</issn>
<issn pub-type="epub">1878-5905</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27267631</article-id>
<article-id pub-id-type="pmc">5379995</article-id>
<article-id pub-id-type="doi">10.1016/j.biomaterials.2016.05.044</article-id>
<article-id pub-id-type="manuscript">NIHMS852969</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nanoscale effects in dendrimer-mediated targeting of neuroinflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nance</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="author-notes" rid="FN3">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Fan</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mishra</surname>
<given-names>Manoj K.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kambhampati</surname>
<given-names>Siva P.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kannan</surname>
<given-names>Rangaramanujam M.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
<xref ref-type="aff" rid="A6">f</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
<!--<email>krangar1@jhmi.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kannan</surname>
<given-names>Sujatha</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
<xref ref-type="aff" rid="A6">f</xref>
<xref ref-type="author-notes" rid="FN2">**</xref>
<!--<email>skannan3@jhmi.edu</email>-->
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</aff>
<aff id="A2"><label>b</label>Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21218, USA</aff>
<aff id="A3"><label>c</label>Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA</aff>
<aff id="A4"><label>d</label>Center for Nanomedicine, Department of Ophthalmology, Wilmer Eye Institute Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA</aff>
<aff id="A5"><label>e</label>Hugo Moser Research Institute, Kennedy-Krieger Institute, Baltimore, MD 21205, USA</aff>
<aff id="A6"><label>f</label>Kennedy Krieger Institute â€“ Johns Hopkins University for Cerebral Palsy Research Excellence, Baltimore, MD 21287, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author. Center for Nanomedicine, Department of Ophthalmology, Wilmer Eye Institute Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA</corresp>
<corresp id="FN2"><label>**</label>Corresponding author. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA</corresp>
<fn fn-type="present-address" id="FN3">
<label>1</label>
<p>Current address: Department of Chemical Engineering, University of Washington, Seattle WA, 98195.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>04</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>101</volume>
<fpage>96</fpage>
<lpage>107</lpage>
<!--elocation-id from pubmed: 10.1016/j.biomaterials.2016.05.044-->
<abstract>
<p id="P1">Neuroinflammation, mediated by activated microglia and astrocytes, plays a key role in the pathogenesis of many neurological disorders. Systemically-administered dendrimers target neuroinflammation and deliver drugs with significant efficacy, without the need for ligands. Elucidating the nanoscale aspects of targeting neuroinflammation will enable superior nanodevices for eventual translation. Using a rabbit model of cerebral palsy, we studied the <italic>in vivo</italic> contributions of dendrimer physicochemical properties and disease pathophysiology on dendrimer brain uptake, diffusion, and cell specific localization. Neutral dendrimers move efficiently within the brain parenchyma and rapidly localize in glial cells in regions of injury. Dendrimer uptake is also dependent on the extent of blood-brain-barrier breakdown, glial activation, and disease severity (mild, moderate, or severe), which can lend the dendrimer to be used as an imaging biomarker for disease phenotype. This new understanding of the <italic>in vivo</italic> mechanism of dendrimer-mediated delivery in a clinically-relevant rabbit model provides greater opportunity for clinical translation of targeted brain injury therapies.</p>
</abstract>
<kwd-group>
<kwd>Nanoparticle</kwd>
<kwd>Dendrimer</kwd>
<kwd>Neuroinflammation</kwd>
<kwd>Brain injury</kwd>
<kwd>Glia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>